Development of contrast enhancing agents in magnetic resonance imaging.
Magnetic Resonance Imaging (MRI) is a powerful new diagnostic tool in medicine. In MRI there is a great need to improve the specific identification of different tissues i.e. to enhance the contrast between them. This review tries to cover most of the approaches known for solving this problem.
Lex
L
L
Department of Biophysics, University Medical School, Pécs, Hungary.
D000818:Animals; D000906:Antibodies; D003287:Contrast Media; D005290:Ferric Compounds; D019786:Gadolinium DTPA; D006571:Heterocyclic Compounds; D006801:Humans; D008081:Liposomes; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009589:Nitrogen Oxides; D009942:Organometallic Compounds; D004369:Pentetic Acid; D011166:Porphyrins
D000906:Antibodies; D003287:Contrast Media; D005290:Ferric Compounds; D006571:Heterocyclic Compounds; D008081:Liposomes; D009589:Nitrogen Oxides; D009942:Organometallic Compounds; D011166:Porphyrins; C001215:ferrite; D004369:Pentetic Acid; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; C039900:nitroxyl; D019786:Gadolinium DTPA